Brief: Kashiv Biosciences Agrees To Be Acquired By Amneal Pharmaceuticals To Create A Fully Integrated Global Biosimilar Leader
22/04/2026 11:54
April 22 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O: KASHIV BIOSCIENCES AGREES TO BE ACQUIRED BY AMNEAL PHARMACEUTICALS TO CREATE A FULLY INTEGRATED GLOBAL BIOSIMILAR LEADER AMNEAL PHARMA: TRANSACTION IS EXPECTED TO CLOSE IN SECOND HALF OF 2026 Source text: ID:nBw3RFG5Va Further company coverage: AMRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsUS FDA is working with manufacturers to boost estrogen patch supply amid access concerns (updated)
U.S. RESEARCH ROUNDUP- Intuit, MongoDB, Zscaler
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
Amneal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Mastercard, Starbucks, Meta